Gideon Dreyfuss

Gideon Dreyfuss is the Isaac Norris Professor in the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. He maintains an active research laboratory focusing on RNA biology and its implications for human disease. His work bridges basic molecular mechanisms with therapeutic applications, particularly in neurodegenerative disorders.

Dr. Dreyfuss received his B.Sc. in Chemistry from The Hebrew University in Jerusalem (1973), M.Sc. in Biochemistry from Tel Aviv University (1975), and Ph.D. in Biological Chemistry from Harvard University (1978). His educational background provided the foundation for his pioneering work in RNA-protein interactions.

His research primarily focuses on RNA-binding proteins, the Survival of Motor Neurons (SMN) complex, and their roles in spinal muscular atrophy and other neurodegenerative diseases. Dr. Dreyfuss has made seminal contributions to understanding the assembly and transport of RNA-protein (RNP) complexes, the exon-junction complex, and U1 snRNP telescripting. His laboratory employs high-throughput screening approaches to identify potential therapeutics for spinal muscular atrophy. The keywords that define his research include RNA, RNPs, SMN, spinal muscular atrophy, high throughput screening, neurodegeneration, and nuclear transport.

Analysis of his recent publications (2013-2025) reveals a consistent focus on RNA-protein interactions, with particular emphasis on U1 snRNP functions in transcription regulation and telescripting. His work has evolved from basic characterization of RNA-binding proteins to therapeutic applications for neuromuscular diseases, demonstrating a clear trajectory from fundamental science to clinical relevance.

Dr. Dreyfuss leads an active laboratory with numerous research associates, postdoctoral fellows, and specialists working on various aspects of RNA biology. His laboratory has been consistently funded through competitive grants, supporting research on SMN complex composition, function, and therapeutic targeting for spinal muscular atrophy.

The Dreyfuss laboratory maintains a robust team structure with specialized personnel focusing on different aspects of RNA biology. Current lab members include research associates, postdoctoral fellows, and specialists working on SMN complex structure, U1 snRNP functions, and high-throughput screening for therapeutic compounds. The laboratory has established sophisticated methodologies for studying RNA-protein interactions and their implications for human disease.